Page 3 - Base Genomics News Today

- Craig Fox PhD, former CSO of C4X Discovery joins as Operating Partner, Life Sciences - Caroline Cake MBA, MEng, former CEO of Health Data Research UK, joins as Entrepreneur in Residence

/PRNewswire/ -- Oxford Science Enterprises, the Science Business Builder and preferred intellectual property partner of the University of Oxford, today...

Exact Sciences Corp. has acquired Marshfield-based genetic testing laboratory PreventionGenetics for $190 million.

/PRNewswire/ -- According to The Insight Partners study on "Genomics Market to 2027 – Global Analysis and Forecast – by Technology, Product and Sevice,...

The growth of the genomics market is attributed to the increasing prevalence of chronic diseases, declining cost of sequencing procedures, and growing funding for genomics. However, the lack

/PRNewswire/ -- According to The Insight Partners study on "Genomics Market to 2027 – Global Analysis and Forecast – by Technology, Product and Sevice,...

ARK Fintech Innovation ETF and the ARK Next Generation Internet ETF. The digital payment companys share price soared in 2020 after the coronavirus pandemic forced people to rapidly transition from an in-person to an online way of life. Although the stock fell almost 30% from its all-time high during the February tech sell-off, it now seems to be on a path of recovery. The digital payments market was estimated to be worth $58.3 billion in 2020 and is expected to grow at a compound annual growth...

SHELLEY K. MESCH When Exact Sciences moved to Madison from Boston in 2009, the company had 20 employees and the intention of developing a colon cancer screening test. Now, millions of people are screened each year using Exact Sciences’ Cologuard, the company employs more than 5,000 people, and multiple tests are in development for various types and aspects of cancer. In the last three years, Exact Sciences has broadened its diagnostic abilities by acquiring several companies an...

Share: Ark Funds hosted an investor webinar Tuesday, sharing ideas on several industries and portfolio components, including a discussion on some names in the genomics space. Ark Funds On Genomics: Ark Funds is well-known for its bullish thesis on the genomics market. The company has the Ark Genomic Revolution ETF (BATS: ARKG), an ETF devoted to the growth of the segment. Exact Sciences (NASDAQ: EXAS) was highlighted by Ark Funds analyst Simon Barnett. The company has made a series of acquis...

Rexnord, Regal Beloit merger headlines recent big deals in region Share Rexnord Corp. There has been plenty of merger and acquisition activity in Wisconsin in the past year, even after the COVID-19 pandemic introduced new uncertainty and slowed the pace of deals for several months.  One of the… Want to Read More? There has been plenty of merger and acquisition activity in Wisconsin in the past year, even after the COVID-19 pandemic introduced new uncertainty and slowed the pace of deals for...